ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human GM-CSF for Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35V15860
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human GM CSF for Injection Market Research Report 2023
BUY CHAPTERS

Global Recombinant Human GM-CSF for Injection Market Research Report 2025

Code: QYRE-Auto-35V15860
Report
May 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Changchun GeneScience
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Baidi Biotechnology

Recombinant Human GM-CSF for Injection Market Size

The global market for Recombinant Human GM-CSF for Injection was valued at US$ 94.1 million in the year 2024 and is projected to reach a revised size of US$ 122 million by 2031, growing at a CAGR of 3.8% during the forecast period.

Recombinant Human GM-CSF for Injection Market

Recombinant Human GM-CSF for Injection Market

Recombinant Human GM-CSF for Injection is a biopharmaceutical product that plays a critical role in stimulating the growth and function of granulocytes and macrophages, key components of the immune system. It is used to treat various medical conditions, including neutropenia, leukemia, and as an adjunct therapy for certain cancer treatments. The market for this product is substantial, driven by the rising prevalence of diseases that compromise the immune system and the development of immunotherapies. Its future development is likely to involve expanded applications in immune-related therapies, further improving patient outcomes in the treatment of various disorders.
Recombinant Human GM-CSF for Injection is a crucial biopharmaceutical product widely used in the treatment of various diseases, particularly leukemia and malignant tumors. The market for this product is substantial and continuously expanding, driven by advancements in medical technology and therapeutic approaches. In the future, it is expected that this field will continue to evolve, with specific uses of recombinant human GM-CSF potentially extending to include the treatment of more cancer types, offering further growth opportunities in the biopharmaceutical industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human GM-CSF for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human GM-CSF for Injection.
The Recombinant Human GM-CSF for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human GM-CSF for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human GM-CSF for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human GM-CSF for Injection Market Report

Report Metric Details
Report Name Recombinant Human GM-CSF for Injection Market
Accounted market size in year US$ 94.1 million
Forecasted market size in 2031 US$ 122 million
CAGR 3.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 75ug
  • 150ug
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Changchun GeneScience, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Baidi Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human GM-CSF for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human GM-CSF for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant Human GM-CSF for Injection Market growing?

Ans: The Recombinant Human GM-CSF for Injection Market witnessing a CAGR of 3.8% during the forecast period 2025-2031.

What is the Recombinant Human GM-CSF for Injection Market size in 2031?

Ans: The Recombinant Human GM-CSF for Injection Market size in 2031 will be US$ 122 million.

Who are the main players in the Recombinant Human GM-CSF for Injection Market report?

Ans: The main players in the Recombinant Human GM-CSF for Injection Market are Sanofi, Changchun GeneScience, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Baidi Biotechnology

What are the Application segmentation covered in the Recombinant Human GM-CSF for Injection Market report?

Ans: The Applications covered in the Recombinant Human GM-CSF for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Recombinant Human GM-CSF for Injection Market report?

Ans: The Types covered in the Recombinant Human GM-CSF for Injection Market report are 75ug, 150ug

Recommended Reports

Recombinant Drugs

Cell and Gene Therapy

Oncology Treatments

1 Recombinant Human GM-CSF for Injection Market Overview
1.1 Product Definition
1.2 Recombinant Human GM-CSF for Injection by Type
1.2.1 Global Recombinant Human GM-CSF for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 75ug
1.2.3 150ug
1.3 Recombinant Human GM-CSF for Injection by Application
1.3.1 Global Recombinant Human GM-CSF for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Recombinant Human GM-CSF for Injection Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human GM-CSF for Injection Revenue 2020-2031
1.4.2 Global Recombinant Human GM-CSF for Injection Sales 2020-2031
1.4.3 Global Recombinant Human GM-CSF for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human GM-CSF for Injection Market Competition by Manufacturers
2.1 Global Recombinant Human GM-CSF for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human GM-CSF for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human GM-CSF for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human GM-CSF for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human GM-CSF for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human GM-CSF for Injection, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human GM-CSF for Injection, Date of Enter into This Industry
2.8 Global Recombinant Human GM-CSF for Injection Market Competitive Situation and Trends
2.8.1 Global Recombinant Human GM-CSF for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human GM-CSF for Injection Players Market Share by Revenue
2.8.3 Global Recombinant Human GM-CSF for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human GM-CSF for Injection Market Scenario by Region
3.1 Global Recombinant Human GM-CSF for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human GM-CSF for Injection Sales by Region: 2020-2031
3.2.1 Global Recombinant Human GM-CSF for Injection Sales by Region: 2020-2025
3.2.2 Global Recombinant Human GM-CSF for Injection Sales by Region: 2026-2031
3.3 Global Recombinant Human GM-CSF for Injection Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human GM-CSF for Injection Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human GM-CSF for Injection Revenue by Region: 2026-2031
3.4 North America Recombinant Human GM-CSF for Injection Market Facts & Figures by Country
3.4.1 North America Recombinant Human GM-CSF for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human GM-CSF for Injection Sales by Country (2020-2031)
3.4.3 North America Recombinant Human GM-CSF for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human GM-CSF for Injection Market Facts & Figures by Country
3.5.1 Europe Recombinant Human GM-CSF for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human GM-CSF for Injection Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human GM-CSF for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human GM-CSF for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human GM-CSF for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human GM-CSF for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human GM-CSF for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human GM-CSF for Injection Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human GM-CSF for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human GM-CSF for Injection Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human GM-CSF for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human GM-CSF for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human GM-CSF for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human GM-CSF for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human GM-CSF for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human GM-CSF for Injection Sales by Type (2020-2031)
4.1.1 Global Recombinant Human GM-CSF for Injection Sales by Type (2020-2025)
4.1.2 Global Recombinant Human GM-CSF for Injection Sales by Type (2026-2031)
4.1.3 Global Recombinant Human GM-CSF for Injection Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human GM-CSF for Injection Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human GM-CSF for Injection Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human GM-CSF for Injection Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human GM-CSF for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human GM-CSF for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human GM-CSF for Injection Sales by Application (2020-2031)
5.1.1 Global Recombinant Human GM-CSF for Injection Sales by Application (2020-2025)
5.1.2 Global Recombinant Human GM-CSF for Injection Sales by Application (2026-2031)
5.1.3 Global Recombinant Human GM-CSF for Injection Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human GM-CSF for Injection Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human GM-CSF for Injection Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human GM-CSF for Injection Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human GM-CSF for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human GM-CSF for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Recombinant Human GM-CSF for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Recombinant Human GM-CSF for Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Changchun GeneScience
6.2.1 Changchun GeneScience Company Information
6.2.2 Changchun GeneScience Description and Business Overview
6.2.3 Changchun GeneScience Recombinant Human GM-CSF for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Changchun GeneScience Recombinant Human GM-CSF for Injection Product Portfolio
6.2.5 Changchun GeneScience Recent Developments/Updates
6.3 Hainan Unipul Pharmaceutical
6.3.1 Hainan Unipul Pharmaceutical Company Information
6.3.2 Hainan Unipul Pharmaceutical Description and Business Overview
6.3.3 Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Product Portfolio
6.3.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
6.4 Harbin Pharmaceutical Group
6.4.1 Harbin Pharmaceutical Group Company Information
6.4.2 Harbin Pharmaceutical Group Description and Business Overview
6.4.3 Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Product Portfolio
6.4.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.5 Guangzhou Baiyunshan Baidi Biotechnology
6.5.1 Guangzhou Baiyunshan Baidi Biotechnology Company Information
6.5.2 Guangzhou Baiyunshan Baidi Biotechnology Description and Business Overview
6.5.3 Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Product Portfolio
6.5.5 Guangzhou Baiyunshan Baidi Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human GM-CSF for Injection Industry Chain Analysis
7.2 Recombinant Human GM-CSF for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human GM-CSF for Injection Production Mode & Process Analysis
7.4 Recombinant Human GM-CSF for Injection Sales and Marketing
7.4.1 Recombinant Human GM-CSF for Injection Sales Channels
7.4.2 Recombinant Human GM-CSF for Injection Distributors
7.5 Recombinant Human GM-CSF for Injection Customer Analysis
8 Recombinant Human GM-CSF for Injection Market Dynamics
8.1 Recombinant Human GM-CSF for Injection Industry Trends
8.2 Recombinant Human GM-CSF for Injection Market Drivers
8.3 Recombinant Human GM-CSF for Injection Market Challenges
8.4 Recombinant Human GM-CSF for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Changchun GeneScience
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Baidi Biotechnology
List of Tables
 Table 1. Global Recombinant Human GM-CSF for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human GM-CSF for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human GM-CSF for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human GM-CSF for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human GM-CSF for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human GM-CSF for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human GM-CSF for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human GM-CSF for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human GM-CSF for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human GM-CSF for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human GM-CSF for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human GM-CSF for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human GM-CSF for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human GM-CSF for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human GM-CSF for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human GM-CSF for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Human GM-CSF for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human GM-CSF for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Human GM-CSF for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human GM-CSF for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human GM-CSF for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human GM-CSF for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human GM-CSF for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human GM-CSF for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human GM-CSF for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Human GM-CSF for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Human GM-CSF for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human GM-CSF for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human GM-CSF for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human GM-CSF for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Human GM-CSF for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Human GM-CSF for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human GM-CSF for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human GM-CSF for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human GM-CSF for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Human GM-CSF for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Human GM-CSF for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human GM-CSF for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human GM-CSF for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human GM-CSF for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Human GM-CSF for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Human GM-CSF for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human GM-CSF for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human GM-CSF for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human GM-CSF for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Human GM-CSF for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Human GM-CSF for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human GM-CSF for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human GM-CSF for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Human GM-CSF for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Human GM-CSF for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human GM-CSF for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human GM-CSF for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human GM-CSF for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human GM-CSF for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human GM-CSF for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human GM-CSF for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Human GM-CSF for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Human GM-CSF for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Human GM-CSF for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Human GM-CSF for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human GM-CSF for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human GM-CSF for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human GM-CSF for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human GM-CSF for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human GM-CSF for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human GM-CSF for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Human GM-CSF for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Recombinant Human GM-CSF for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Recombinant Human GM-CSF for Injection Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Changchun GeneScience Company Information
 Table 76. Changchun GeneScience Description and Business Overview
 Table 77. Changchun GeneScience Recombinant Human GM-CSF for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Changchun GeneScience Recombinant Human GM-CSF for Injection Product
 Table 79. Changchun GeneScience Recent Developments/Updates
 Table 80. Hainan Unipul Pharmaceutical Company Information
 Table 81. Hainan Unipul Pharmaceutical Description and Business Overview
 Table 82. Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hainan Unipul Pharmaceutical Recombinant Human GM-CSF for Injection Product
 Table 84. Hainan Unipul Pharmaceutical Recent Developments/Updates
 Table 85. Harbin Pharmaceutical Group Company Information
 Table 86. Harbin Pharmaceutical Group Description and Business Overview
 Table 87. Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Harbin Pharmaceutical Group Recombinant Human GM-CSF for Injection Product
 Table 89. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 90. Guangzhou Baiyunshan Baidi Biotechnology Company Information
 Table 91. Guangzhou Baiyunshan Baidi Biotechnology Description and Business Overview
 Table 92. Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Guangzhou Baiyunshan Baidi Biotechnology Recombinant Human GM-CSF for Injection Product
 Table 94. Guangzhou Baiyunshan Baidi Biotechnology Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Recombinant Human GM-CSF for Injection Distributors List
 Table 98. Recombinant Human GM-CSF for Injection Customers List
 Table 99. Recombinant Human GM-CSF for Injection Market Trends
 Table 100. Recombinant Human GM-CSF for Injection Market Drivers
 Table 101. Recombinant Human GM-CSF for Injection Market Challenges
 Table 102. Recombinant Human GM-CSF for Injection Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human GM-CSF for Injection
 Figure 2. Global Recombinant Human GM-CSF for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human GM-CSF for Injection Market Share by Type: 2024 & 2031
 Figure 4. 75ug Product Picture
 Figure 5. 150ug Product Picture
 Figure 6. Global Recombinant Human GM-CSF for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Human GM-CSF for Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Recombinant Human GM-CSF for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Human GM-CSF for Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Human GM-CSF for Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Recombinant Human GM-CSF for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Recombinant Human GM-CSF for Injection Report Years Considered
 Figure 16. Recombinant Human GM-CSF for Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Human GM-CSF for Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Human GM-CSF for Injection Players: Market Share by Revenue in Recombinant Human GM-CSF for Injection in 2024
 Figure 19. Recombinant Human GM-CSF for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Human GM-CSF for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Human GM-CSF for Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Human GM-CSF for Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Human GM-CSF for Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Human GM-CSF for Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Human GM-CSF for Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Human GM-CSF for Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Recombinant Human GM-CSF for Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Recombinant Human GM-CSF for Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Recombinant Human GM-CSF for Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Recombinant Human GM-CSF for Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Recombinant Human GM-CSF for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Recombinant Human GM-CSF for Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Recombinant Human GM-CSF for Injection by Type (2020-2031)
 Figure 53. Global Recombinant Human GM-CSF for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Recombinant Human GM-CSF for Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Human GM-CSF for Injection by Application (2020-2031)
 Figure 56. Global Recombinant Human GM-CSF for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Recombinant Human GM-CSF for Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2025
Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030
Global Recombinant Human M CSF Protein Market Research Report 2025
Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Filgrastim Injection Market Research Report 2024
Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Pegfilgrastim Market Insights Forecast to 2030
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF ELISA Kit Market Research Report 2024
Global Macrophage Colony Stimulating Factor Reagent Market Research Report 2025
Global PEG rhG CSF Market Research Report 2025
Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global Granulocyte Colony stimulating Factor G CSF ELISA Kit Market Research Report 2024
Global PEGylated Granulocyte Colony Stimulating Factor Market Research Report 2024
Global Recombinant Human Erythropoietin Injection Market Research Report 2025
Pegfilgrastim Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Tumor Necrosis Factor α ReceptorⅡ IgG Fc Fusion Protein for Injection Market Research Report 2024
Global Filgrastim Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions